In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab

Djordje Atanackovic, Sara Yousef, Christa Shorter, Srinivas K. Tantravahi, Mary Steinbach, Fiorella Iglesias, Douglas Sborov, Sabarinath Venniyil Radhakrishnan, Marielle Chiron, Rodney Miles, Mohamed Salama, Nicolaus Kröger, Tim Luetkens

Research output: Contribution to journalLetter

3 Scopus citations
Original languageEnglish (US)
JournalLeukemia
DOIs
StateAccepted/In press - Jan 1 2019

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Atanackovic, D., Yousef, S., Shorter, C., Tantravahi, S. K., Steinbach, M., Iglesias, F., Sborov, D., Radhakrishnan, S. V., Chiron, M., Miles, R., Salama, M., Kröger, N., & Luetkens, T. (Accepted/In press). In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab. Leukemia. https://doi.org/10.1038/s41375-019-0536-3